Co-Administration of Thymoquinone and Propolis in Liposomal Formulations as a Potential Approach for Treatment of Acetic Acid-Induced Ulcerative Colitis: Physiological and Histopathological Analysis

Scientists assessed the potential of liposomal formulations of thymoquinone and Egyptian propolis extract in combination therapy to improve their therapeutic efficacy against ulcerative colitis in order to maximize the potential of their beneficial clinical effects.